RESUMEN
Protein zero (P0) is the major structural protein in peripheral myelin, and mutations in the Myelin Protein Zero (Mpz) gene produce wide-ranging hereditary neuropathy phenotypes. To gain insight in the mechanisms underlying a particularly severe form, congenital hypomyelination (CH), we targeted mouse Mpz to encode P0Q215X, a nonsense mutation associated with the disease, that we show escapes nonsense mediated decay and is expressed in CH patient nerves. The knock-in mice express low levels of the resulting truncated protein, producing a milder phenotype when compared to patients, allowing to dissect the subtle pathogenic mechanisms occurring in otherwise very compromised peripheral myelin. We find that P0Q215X does not elicit an unfolded protein response, which is a key mechanism for other pathogenic MPZ mutations, but is instead in part aberrantly trafficked to non-myelin plasma membranes and induces defects in radial sorting of axons by Schwann cells. We show that the loss of the C-terminal Tyr-Ala-Met-Leu motif is responsible for P0 mislocalization, as its addition is able to restore correct P0Q215X trafficking in vitro. Lastly, we show that P0Q215X acts through dose-dependent gain of abnormal function, as wild-type P0 is unable to rescue the hypomyelination phenotype. Collectively, these data indicate that alterations at the premyelinating stage, linked to altered targeting of P0, may be responsible for CH, and that different types of gain of abnormal function produce the diverse neuropathy phenotypes associated with MPZ, supporting future allele-specific therapeutic silencing strategies.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/genética , Proteína P0 de la Mielina/genética , Proteína P0 de la Mielina/fisiología , Animales , Axones/metabolismo , Membrana Celular/fisiología , Codón sin Sentido , Enfermedades Desmielinizantes/genética , Femenino , Técnicas de Sustitución del Gen , Humanos , Masculino , Ratones Endogámicos BALB C , Mutación , Fenotipo , Transporte de Proteínas/genética , Células de Schwann/metabolismoRESUMEN
Chronic inflammatory demyelinating polyneuropathy is a debilitating autoimmune disease characterized by peripheral nerve demyelination and dysfunction. How the autoimmune response is initiated, identity of provoking Ags, and pathogenic effector mechanisms are not well defined. The autoimmune regulator (Aire) plays a critical role in central tolerance by promoting thymic expression of self-Ags and deletion of self-reactive T cells. In this study, we used mice with hypomorphic Aire function and two patients with Aire mutations to define how Aire deficiency results in spontaneous autoimmune peripheral neuropathy. Autoimmunity against peripheral nerves in both mice and humans targets myelin protein zero, an Ag for which expression is Aire-regulated in the thymus. Consistent with a defect in thymic tolerance, CD4(+) T cells are sufficient to transfer disease in mice and produce IFN-γ in infiltrated peripheral nerves. Our findings suggest that defective Aire-mediated central tolerance to myelin protein zero initiates an autoimmune Th1 effector response toward peripheral nerves.
Asunto(s)
Tolerancia Inmunológica , Proteína P0 de la Mielina/deficiencia , Mutación Puntual , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/inmunología , Factores de Transcripción/deficiencia , Factores de Transcripción/genética , Secuencia de Aminoácidos , Animales , Autoanticuerpos/sangre , Modelos Animales de Enfermedad , Femenino , Humanos , Tolerancia Inmunológica/genética , Ratones , Ratones Endogámicos NOD , Ratones Mutantes , Ratones SCID , Datos de Secuencia Molecular , Proteína P0 de la Mielina/genética , Proteína P0 de la Mielina/fisiología , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/sangre , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/genética , Factores de Transcripción/fisiología , Proteína AIRERESUMEN
OBJECTIVE: On the basis of the hypothesis that copy number mutations of the genes encoding myelin compact proteins are responsible for myelin disorders in humans, we have explored the possibility of copy number mutations in patients with Charcot-Marie-Tooth disease (CMT) whose responsible genes remain undefined. METHODS: A family with 6 affected members in 3 consecutive generations, presenting with motor and sensory demyelinating polyneuropathy, was investigated. Characteristic clinical features in this pedigree include Adie pupils and substantial intrafamilial variability in the age at onset, electrophysiological findings, and clinical severity. Nucleotide sequence analyses of PMP22, MPZ, or GJB1 and gene dosage study of PMP22 did not reveal causative mutations. Hence, we applied a custom-designed array for comparative genomic hybridization (CGH) analysis to conduct a comprehensive screening of copy number mutations involving any of the known causative genes for CMT other than PMP22. RESULTS: The array CGH analyses revealed increased gene dosage involving the whole MPZ, and the flanking genes of SDHC and C1orf192. The gene dosage is estimated to be 5 copies. This mutation showed complete cosegregation with the disease phenotype in this pedigree. INTERPRETATION: The increased gene dosage of MPZ and increased expression level of MPZ mRNA emphasize the important role of the dosage of the MPZ protein in the functional integrity of peripheral nerve myelin in humans, and provide a new insight into the pathogenic mechanisms underlying CMT.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/genética , Dosificación de Gen/genética , Proteína P0 de la Mielina/genética , Adulto , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Femenino , Ligamiento Genético/genética , Humanos , Masculino , Persona de Mediana Edad , Proteína P0 de la Mielina/fisiología , LinajeRESUMEN
Mice with a heterozygous knock-out of the myelin protein P0 gene (P0+/-) develop a neuropathy similar to human Charcot-Marie-Tooth disease. They are indistinguishable from wild-types (WT) at birth and develop a slowly progressing demyelinating neuropathy. The aim of this study was to investigate whether the regeneration capacity of early symptomatic P0+/- is impaired as compared to age matched WT. Right sciatic nerves were lesioned at the thigh in 7-8 months old mice. Tibial motor axons at ankle were investigated by conventional motor conduction studies and axon excitability studies using threshold tracking. To evaluate regeneration we monitored the recovery of motor function after crush, and then compared the fiber distribution by histology. The overall motor performance was investigated using Rotor-Rod. P0+/- had reduced compound motor action potential amplitudes and thinner myelinated axons with only a borderline impairment in conduction and Rotor-Rod. Plantar muscle reinnervation occurred within 21 days in all mice. Shortly after reinnervation the conduction of P0+/- regenerated axons was markedly slower than WT, however, this difference decayed with time. Nevertheless, after 1 month, regenerated P0+/- axons had longer strength-duration time constant, larger threshold changes during hyperpolarizing electrotonus and longer relative refractory period. Their performance at Rotor-Rod remained also markedly impaired. In contrast, the number and diameter distribution of regenerating myelinated fibers became similar to regenerated WT. Our data suggest that in the presence of heterozygously P0 deficient Schwann cells, regenerating motor axons retain their ability to reinnervate their targets and remyelinate, though their functional recovery is delayed.
Asunto(s)
Axones/fisiología , Neuronas Motoras/fisiología , Proteína P0 de la Mielina/fisiología , Regeneración Nerviosa/fisiología , Potenciales de Acción/fisiología , Animales , Axones/patología , Conducta Animal , Enfermedad de Charcot-Marie-Tooth/fisiopatología , Modelos Animales de Enfermedad , Heterocigoto , Ratones , Proteína P0 de la Mielina/genética , Conducción Nerviosa/fisiología , Equilibrio Postural , Desempeño Psicomotor , Prueba de Desempeño de Rotación con Aceleración Constante , Nervio Tibial/fisiologíaRESUMEN
Mutations in myelin protein zero (MPZ) cause Charcot-Marie-Tooth disease type 1B. Many dominant MPZ mutations, including R98C, present as infantile onset dysmyelinating neuropathies. We have generated an R98C 'knock-in' mouse model of Charcot-Marie-Tooth type 1B, where a mutation encoding R98C was targeted to the mouse Mpz gene. Both heterozygous (R98C/+) and homozygous (R98C/R98C) mice develop weakness, abnormal nerve conduction velocities and morphologically abnormal myelin; R98C/R98C mice are more severely affected. MpzR98C is retained in the endoplasmic reticulum of Schwann cells and provokes a transitory, canonical unfolded protein response. Ablation of Chop, a mediator of the protein kinase RNA-like endoplasmic reticulum kinase unfolded protein response pathway restores compound muscle action potential amplitudes of R98C/+ mice but does not alter the reduced conduction velocities, reduced axonal diameters or clinical behaviour of these animals. R98C/R98C Schwann cells are developmentally arrested in the promyelinating stage, whereas development is delayed in R98C/+ mice. The proportion of cells expressing c-Jun, an inhibitor of myelination, is elevated in mutant nerves, whereas the proportion of cells expressing the promyelinating transcription factor Krox-20 is decreased, particularly in R98C/R98C mice. Our results provide a potential link between the accumulation of MpzR98C in the endoplasmic reticulum and a developmental delay in myelination. These mice provide a model by which we can begin to understand the early onset dysmyelination seen in patients with R98C and similar mutations.
Asunto(s)
Diferenciación Celular/fisiología , Enfermedad de Charcot-Marie-Tooth/fisiopatología , Modelos Animales de Enfermedad , Proteína P0 de la Mielina/fisiología , Células de Schwann/citología , Células de Schwann/metabolismo , Potenciales de Acción/fisiología , Animales , Axones/patología , Axones/fisiología , Axones/ultraestructura , Enfermedad de Charcot-Marie-Tooth/genética , Enfermedad de Charcot-Marie-Tooth/patología , Proteína 2 de la Respuesta de Crecimiento Precoz/metabolismo , Retículo Endoplásmico/metabolismo , Regulación del Desarrollo de la Expresión Génica/fisiología , Técnicas de Sustitución del Gen/métodos , Ratones , Ratones Noqueados , Ratones Transgénicos , Mutación , Proteína P0 de la Mielina/genética , Vaina de Mielina/genética , Vaina de Mielina/patología , Conducción Nerviosa/fisiología , Proteínas Proto-Oncogénicas c-jun/biosíntesis , Prueba de Desempeño de Rotación con Aceleración Constante/métodos , Células de Schwann/ultraestructura , Nervio Ciático/patología , Nervio Ciático/fisiopatología , Nervio Ciático/ultraestructura , Factor de Transcripción CHOP/metabolismo , Respuesta de Proteína Desplegada/fisiologíaRESUMEN
Point mutations in "myelin genes" result in a spectrum of inherited demyelinating neuropathies. The understanding of the pathomechanisms by which these mutations produce phenotypes remains limited. In this issue of Neuron, Wrabetz and colleagues report that the unfolded protein response (UPR) is responsible for demyelination in a Charcot-Marie-Tooth disease type 1B (CMT1B) mouse model. Deletion of the UPR mediator transcription factor CHOP completely rescues the motor deficit and ameliorates the neuropathy phenotype.
Asunto(s)
Proteína P0 de la Mielina/fisiología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Pliegue de Proteína , Animales , Enfermedades Desmielinizantes , Modelos Animales de Enfermedad , Ratones , Enfermedades del Sistema Nervioso Periférico/genéticaRESUMEN
Point mutations in the cytoplasmic domain of myelin protein zero (P0; the major myelin protein in the peripheral nervous system) that alter a protein kinase Calpha (PKCalpha) substrate motif (198HRSTK201) or alter serines 199 and/or 204 eliminate P0-mediated adhesion. Mutation in the PKCalpha substrate motif (R198S) also causes a form of inherited peripheral neuropathy (Charcot Marie Tooth disease [CMT] 1B), indicating that PKCalpha-mediated phosphorylation of P0 is important for myelination. We have now identified a 65-kD adaptor protein that links P0 with the receptor for activated C kinase 1 (RACK1). The interaction of p65 with P0 maps to residues 179-197 within the cytoplasmic tail of P0. Mutations or deletions that abolish p65 binding reduce P0 phosphorylation and adhesion, which can be rescued by the substitution of serines 199 and 204 with glutamic acid. A mutation in the p65-binding sequence G184R occurs in two families with CMT, and mutation of this residue results in the loss of both p65 binding and adhesion function.
Asunto(s)
Proteínas de Unión al GTP/fisiología , Proteína P0 de la Mielina/metabolismo , Proteínas de Neoplasias/fisiología , Proteína Quinasa C-alfa/fisiología , Receptores de Superficie Celular/fisiología , Proteínas Adaptadoras Transductoras de Señales/fisiología , Secuencia de Aminoácidos , Animales , Humanos , Células L , Ratones , Datos de Secuencia Molecular , Proteína P0 de la Mielina/fisiología , Fosforilación , Ratas , Receptores de Cinasa C Activada , Técnicas del Sistema de Dos HíbridosRESUMEN
Myelin protein zero mutations were found to produce Charcot-Marie-Tooth disease phenotypes with various degrees of myelin impairment and axonal loss, ranging from the mild 'demyelinating' adult form to severe and early onset forms. Protein zero deficient homozygous mice ( ) show a severe and progressive dysmyelinating neuropathy from birth with compromised myelin compaction, hypomyelination and distal axonal degeneration. A previous study using immunofluorescence showed that motor nerves deficient of myelin protein zero upregulate the Na(V)1.8 voltage gated sodium channel isoform, which is normally present only in restricted populations of sensory axons. The aim of this study was to investigate the function of motor axons in protein zero-deficient mice with particular emphasis on ectopic Na(V)1.8 voltage gated sodium channel. We combined 'threshold tracking' excitability studies with conventional nerve conduction studies, behavioural studies using rotor-rod measurements, and histological measures to assess membrane dysfunction and its progression in protein zero deficient homozygous mutants as compared with age-matched wild-type controls. The involvement of Na(V)1.8 was investigated by pharmacologic block using the subtype-selective Na(V)1.8 blocker A-803467 and chronically in Na(V)1.8 knock-outs. We found that in the context of dysmyelination, abnormal potassium ion currents and membrane depolarization, the ectopic Na(V)1.8 channels further impair the motor axon excitability in protein zero deficient homozygous mutants to an extent that precipitates conduction failure in severely affected axons. Our data suggest that a Na(V)1.8 channelopathy contributed to the poor motor function of protein zero deficient homozygous mutants, and that the conduction failure was associated with partially reversible reduction of the electrically evoked muscle response and of the clinical function as indicated by the partial recovery of function at rotor-rod measurements. As a consequence of these findings of partially reversible dysfunction, we propose that the Na(V)1.8 voltage gated sodium channel should be considered as a novel therapeutic target for Charcot-Marie-Tooth disease.
Asunto(s)
Axones/metabolismo , Axones/fisiología , Canalopatías/fisiopatología , Neuronas Motoras/fisiología , Proteína P0 de la Mielina/fisiología , Canales de Sodio/fisiología , Nervio Tibial/fisiopatología , Compuestos de Anilina/farmacología , Animales , Axones/patología , Canalopatías/genética , Canalopatías/patología , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/fisiopatología , Furanos/farmacología , Ratones , Ratones Noqueados , Ratones Mutantes Neurológicos , Neuronas Motoras/metabolismo , Neuronas Motoras/patología , Proteína P0 de la Mielina/genética , Canal de Sodio Activado por Voltaje NAV1.8 , Conducción Nerviosa/efectos de los fármacos , Conducción Nerviosa/fisiología , Prueba de Desempeño de Rotación con Aceleración Constante , Bloqueadores de los Canales de Sodio/farmacología , Canales de Sodio/efectos de los fármacos , Nervio Tibial/patologíaRESUMEN
Myelin protein zero (P0) is the major structural element of peripheral myelin that plays a very important role in maintaining the stability of myelin. Recently, many researches find that the structure, distribution and function of P0 have transcended people's early understanding. In this review, the basic features of structure, distribution and function of P0 and its current research advances in neurotoxicology are simply summarized.
Asunto(s)
Enfermedades Autoinmunes/fisiopatología , Proteína P0 de la Mielina , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Animales , Enfermedades Autoinmunes/metabolismo , Enfermedad de Charcot-Marie-Tooth/fisiopatología , Humanos , Mutación , Proteína P0 de la Mielina/genética , Proteína P0 de la Mielina/metabolismo , Proteína P0 de la Mielina/fisiología , Enfermedades del Sistema Nervioso Periférico/metabolismo , Polirradiculoneuropatía/metabolismo , Polirradiculoneuropatía/fisiopatologíaRESUMEN
Axons in the PNS and CNS are ensheathed by multiple layers of tightly compacted myelin membranes. A series of cytoplasmic channels connect outer and inner margins of PNS, but not CNS, myelin internodes. Membranes of these Schmidt-Lantermann (S-L) incisures contain the myelin-associated glycoprotein (MAG) but not P(0) or proteolipid protein (PLP), the structural proteins of compact PNS (P(0)) and CNS (PLP) myelin. We show here that incisures are present in MAG-null and absent from P(0)-null PNS internodes. To test the possibility that P(0) regulates incisure formation, we replaced PLP with P(0) in CNS myelin. S-L incisures formed in P(0)-CNS myelin internodes. Furthermore, axoplasm ensheathed by 65% of the CNS incisures examined by electron microscopy had focal accumulations of organelles, indicating that these CNS incisures disrupt axonal transport. These data support the hypotheses that P(0) protein is required for and can induce S-L incisures and that P(0)-induced CNS incisures can be detrimental to axonal function.
Asunto(s)
Axones/metabolismo , Proteína P0 de la Mielina/fisiología , Vaina de Mielina/metabolismo , Nervios Periféricos/metabolismo , Animales , Axones/ultraestructura , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/ultraestructura , Regulación de la Expresión Génica/genética , Ratones , Ratones Transgénicos , Microscopía Inmunoelectrónica , Proteína P0 de la Mielina/genética , Proteína Proteolipídica de la Mielina/deficiencia , Vaina de Mielina/ultraestructura , Glicoproteína Asociada a Mielina , Nervios Periféricos/citología , Receptores de Superficie Celular/deficienciaRESUMEN
Mice heterozygously deficient in the p0 gene (P0(+/-)) are animal models for some forms of inherited neuropathies. They display a progressive demyelinating phenotype in motor nerves, accompanied by mild infiltration of lymphocytes and increase in macrophages. We have shown previously that the T lymphocytes are instrumental in the demyelination process. This study addresses the functional role of the macrophage in this monogenic myelin disorder. In motor nerves of P0(+/)- mice, the number of macrophages in demyelinated peripheral nerves was increased by a factor of five when compared with motor nerves of wild-type mice. Immunoelectron microscopy, using a specific marker for mouse macrophages, displayed macrophages not only in the endoneurium of the myelin mutants, but also within endoneurial tubes, suggesting an active role in demyelination. To elucidate the roles of the macrophages, we crossbred the myelin mutants with a spontaneous mouse mutant deficient in macrophage colony-stimulating factor (M-CSF), hence displaying impaired macrophage activation. In the P0-deficient double mutants also deficient in M-CSF, the numbers of macrophages were not elevated in the demyelinating motor nerves and demyelination was less severe. These findings demonstrate an active role of macrophages during pathogenesis of inherited demyelination with putative impact on future treatment strategies.
Asunto(s)
Enfermedades Desmielinizantes/fisiopatología , Macrófagos/fisiología , Proteína P0 de la Mielina/fisiología , Vaina de Mielina/fisiología , Nervios Periféricos/fisiología , Raíces Nerviosas Espinales/fisiología , Linfocitos T/fisiología , Animales , Cruzamientos Genéticos , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/inmunología , Modelos Animales de Enfermedad , Nervio Femoral/fisiología , Nervio Femoral/ultraestructura , Heterocigoto , Complejo Mayor de Histocompatibilidad , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Inmunoelectrónica , Proteína P0 de la Mielina/deficiencia , Proteína P0 de la Mielina/genética , Vaina de Mielina/ultraestructura , Nervios Periféricos/ultraestructura , Raíces Nerviosas Espinales/ultraestructuraRESUMEN
Mutations in P0 (MPZ), the major myelin protein of the peripheral nervous system, cause the inherited demyelinating neuropathy Charcot-Marie-Tooth disease type 1B. P0 is a member of the immunoglobulin superfamily and functions as a homophilic adhesion molecule. We now show that point mutations in the cytoplasmic domain that modify a PKC target motif (RSTK) or an adjacent serine residue abolish P0 adhesion function and can cause peripheral neuropathy in humans. Consistent with these data, PKCalpha along with the PKC binding protein RACK1 are immunoprecipitated with wild-type P0, and inhibition of PKC activity abolishes P0-mediated adhesion. Point mutations in the RSTK target site that abolish adhesion do not alter the association of PKC with P0; however, deletion of a 14 amino acid region, which includes the RSTK motif, does abolish the association. Thus, the interaction of PKCalpha with the cytoplasmic domain of P0 is independent of specific target residues but is dependent on a nearby sequence. We conclude that PKC-mediated phosphorylation of specific residues within the cytoplasmic domain of P0 is necessary for P0-mediated adhesion, and alteration of this process can cause demyelinating neuropathy in humans.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/metabolismo , Proteína P0 de la Mielina/metabolismo , Proteína Quinasa C/metabolismo , Secuencia de Aminoácidos , Aminoácidos , Animales , Sitios de Unión , Adhesión Celular/fisiología , Enfermedad de Charcot-Marie-Tooth/genética , Citoplasma/metabolismo , Enfermedades Desmielinizantes , Células HeLa , Humanos , Isoenzimas/metabolismo , Células L , Ratones , Datos de Secuencia Molecular , Proteína P0 de la Mielina/genética , Proteína P0 de la Mielina/fisiología , Péptidos/metabolismo , Fosforilación , Proteína Quinasa C-alfa , Receptores de Cinasa C Activada , Eliminación de SecuenciaRESUMEN
The myelin Po protein is believed to hold myelin together via interactions of both its extracellular and cytoplasmic domains. We have already shown that the extracellular domains of Po can interact in a homophilic manner (Filbin, M.T., F.S. Walsh, B.D. Trapp, J.A. Pizzey, and G.I. Tennekoon. 1990. Nature (Lond.). 344:871-872). In addition, we have shown that for this homophilic adhesion to take place, the cytoplasmic domain of Po must be intact and most likely interacting with the cytoskeleton; Po proteins truncated in their cytoplasmic domains are not adhesive (Wong, M.H., and M.T. Filbin, 1994. J. Cell Biol. 126:1089-1097). To determine if the presence of these truncated forms of Po could have an effect on the functioning of the full-length Po, we coexpressed both molecules in CHO cells. The adhesiveness of CHO cells expressing both full-length Po and truncated Po was then compared to cells expressing only full-length Po. In these coexpressors, both the full-length and the truncated Po proteins were glycosylated. They reached the surface of the cell in approximately equal amounts as shown by an ELISA and surface labeling, followed by immunoprecipitation. Furthermore, the amount of full-length Po at the cell surface was equivalent to other cell lines expressing only full-length Po that we had already shown to be adhesive. Therefore, there should be sufficient levels of full-length Po at the surface of these coexpressors to measure adhesion of Po. However, as assessed by an aggregation assay, the coexpressors were not adhesive. By 60 min they had not formed large aggregates and were indistinguishable from the control transfected cells not expressing Po. In contrast, in the same time, the cells expressing only the full-length Po had formed large aggregates. This indicates that the truncated forms of Po have a dominant-negative effect on the adhesiveness of the full-length Po. Furthermore, from cross-linking studies, full-length Po, when expressed alone but not when coexpressed with truncated Po, appears to cluster in the membrane. We suggest that truncated Po exerts its dominant-negative effect by preventing clustering of full-length Po. We also show that colchicine, which disrupts microtubules, prevents adhesion of cells expressing only the full-length Po. This strengthens our suggestion that an interaction of Po with the cytoskeleton, either directly or indirectly, is required for adhesion to take place.
Asunto(s)
Células CHO/citología , Proteína P0 de la Mielina/química , Proteína P0 de la Mielina/fisiología , Animales , Células CHO/química , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Colchicina/farmacología , Cricetinae , Citocalasinas/farmacología , Citoplasma/química , Citoesqueleto/efectos de los fármacos , Citoesqueleto/fisiología , Expresión Génica/fisiología , Proteínas de la Membrana/fisiología , Microtúbulos/efectos de los fármacos , Microtúbulos/fisiología , Mutagénesis/fisiología , Proteína P0 de la Mielina/genética , Estructura Terciaria de ProteínaRESUMEN
The process of aging deeply influences morphological and functional parameters of peripheral nerves. The observations summarized here indicate that the deterioration of myelin occurring in the peripheral nerves during aging may be explained by the fall of the levels of the major peripheral myelin proteins [e.g., glycoprotein Po (Po) and peripheral myelin protein 22 (PMP22)]. Neuroactive steroids, such as progesterone (PROG), dihydroprogesterone (5alpha-DH PROG), and tetrahydroprogesterone (3alpha,5alpha-TH PROG), are able to stimulate the low expression of these two myelin proteins present in the sciatic nerve of aged male rats. Since Po and PMP22 play an important physiological role in the maintenance of the multilamellar structure of PNS myelin, we have evaluated the effect of PROG and its neuroactive derivatives, 5alpha-DH PROG and 3alpha,5alpha-TH PROG, on the morphological alterations of myelinated fibers in the sciatic nerve of 22-24-month-old male rats. Data obtained clearly indicate that neuroactive steroids are able to reduce aging-associated morphological abnormalities of myelin and aging-associated myelin fiber loss in the sciatic nerve.
Asunto(s)
Envejecimiento , Vaina de Mielina/efectos de los fármacos , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/prevención & control , Progesterona/farmacología , Envejecimiento/patología , Envejecimiento/fisiología , Animales , Masculino , Proteína P0 de la Mielina/efectos de los fármacos , Proteína P0 de la Mielina/fisiología , Proteínas de la Mielina/efectos de los fármacos , Proteínas de la Mielina/fisiología , Enfermedades del Sistema Nervioso Periférico/patología , Progesterona/análogos & derivadosRESUMEN
Mice lacking the major Schwann cell myelin component P0 show a severe dysmyelination with pathological features reminiscent of the Déjérine-Sottas syndrome in humans. Previous morphological and electrophysiological studies on these mice did not only demonstrate a compromised myelination and myelin maintenance, but were suggestive of an impairment of axons as well. Here, we studied the axonal pathology in P0-deficient mice by quantitative electron microscopy. In addition, we investigated epidermal receptor end organs by immunocytochemistry and muscle pathology by histochemistry. In proximal sections of facial and femoral nerves, axon calibers were significantly reduced, whereas the number of myelin-competent axons was not diminished in 5- and 17-month-old P0-deficient mice. However, in distal branches of the femoral and sciatic nerve (digital nerves innervating the skin of the first toe) the numbers of myelin-competent axons were reduced by 70% in 6-month-old P0-deficient mice. Immunolabeling of foot pads revealed a corresponding loss of Merkel cells by 75%, suggesting that survival of these cells is dependent on the presence or maintenance of their innervating myelinated axons. In addition, quadriceps and gastrocnemius muscles showed pathological features indicative of denervation and axonal sprouting. These findings demonstrate that loss of an important myelin component can initiate degenerative mechanisms not only in the Schwann cell but also in the distal portions of myelinated axons, leading to the degeneration of specialized receptor end organs and impairment of muscle innervation.
Asunto(s)
Axones/patología , Células de Merkel/patología , Desnervación Muscular , Músculo Esquelético/inervación , Proteína P0 de la Mielina/fisiología , Animales , Axones/ultraestructura , Nervio Femoral/patología , Nervio Femoral/ultraestructura , Miembro Posterior/inervación , Humanos , Células de Merkel/ultraestructura , Ratones , Ratones Noqueados , Proteína P0 de la Mielina/deficiencia , Proteína P0 de la Mielina/genética , Degeneración Nerviosa/genética , Degeneración Nerviosa/patología , Nervio Ciático/patología , Nervio Ciático/ultraestructura , Dedos del Pie/inervaciónRESUMEN
The adhesive cell surface molecule P(0) is the most abundant glycoprotein in peripheral nerve myelin and fulfills pivotal functions during myelin formation and maintenance. Mutations in the corresponding gene cause hereditary demyelinating neuropathies. In mice heterozygously deficient in P(0) (P(0)(+/-) mice), an established animal model for a subtype of hereditary neuropathies, T-lymphocytes are present in the demyelinating nerves. To monitor the possible involvement of the immune system in myelin pathology, we cross-bred P(0)(+/-) mice with null mutants for the recombination activating gene 1 (RAG-1) or with mice deficient in the T-cell receptor alpha-subunit. We found that in P(0)(+/-) mice myelin degeneration and impairment of nerve conduction properties is less severe when the immune system is deficient. Moreover, isolated T-lymphocytes from P(0)(+/-) mice show enhanced reactivity to myelin components of the peripheral nerve, such as P(0), P(2), and myelin basic protein. We hypothesize that autoreactive immune cells can significantly foster the demyelinating phenotype of mice with a primarily genetically based peripheral neuropathy.
Asunto(s)
Enfermedades Desmielinizantes/fisiopatología , Genes RAG-1 , Proteínas de Homeodominio/fisiología , Síndromes de Inmunodeficiencia/fisiopatología , Proteína P0 de la Mielina/fisiología , Enfermedades del Sistema Nervioso Periférico/genética , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Receptores de Antígenos de Linfocitos T alfa-beta/fisiología , Linfocitos T/inmunología , Animales , Cruzamientos Genéticos , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/patología , Modelos Animales de Enfermedad , Genes Codificadores de la Cadena alfa de los Receptores de Linfocito T , Proteínas de Homeodominio/genética , Síndromes de Inmunodeficiencia/genética , Síndromes de Inmunodeficiencia/patología , Ratones , Ratones Noqueados , Proteína P0 de la Mielina/deficiencia , Proteína P0 de la Mielina/genética , Vaina de Mielina/patología , Vaina de Mielina/fisiología , Degeneración Nerviosa , Conducción Nerviosa , Nervios Periféricos/inmunología , Nervios Periféricos/fisiopatología , Enfermedades del Sistema Nervioso Periférico/patología , Receptores de Antígenos de Linfocitos T alfa-beta/deficiencia , Receptores de Antígenos de Linfocitos T alfa-beta/genéticaRESUMEN
BACKGROUND: Mutations in P0, the major protein of the myelin sheath in peripheral nerves, cause the inherited peripheral neuropathies Charcot-Marie-Tooth disease type 1B (CMT1B), Dejerine-Sottas syndrome (DSS) and congenital hypomyelination (CH). We reported earlier a de novo insertional mutation c.662_663GC (Ala221fs) in a DSS patient. The c.662_663GC insertion results in a frame shift mutation Ala221fs altering the C-terminal amino acid sequence. The adhesion-relevant intracellular RSTK domain is replaced by a sequence similar to Na+/K+ ATPase. To further clarify the molecular disease mechanisms in this sporadic patient we constructed wild type P0 and the c.662_663GC mutant expression cassettes by site-specific mutagenesis and transfected the constructs into insect cells (S2, High5). To trace the effects in live cells, green fluorescent protein (GFP) has been added to the carboxyterminus of the wild type and mutated P0 protein. RESULTS: In contrast to the membrane-localized wild type P0-GFP the Ala221fs P0-GFP protein was detectable almost only in the cytoplasm of the cells, and a complete loss of adhesion function was observed. CONCLUSIONS: The present study provides evidence that GFP is a versatile tool to trace in vivo effects of P0 and its mutations. Not only a loss of adhesion function as a result of the loss of the RSTK domain, but also altered intracellular trafficking indicated by a loss of membrane insertion are possible consequences of the Ala221fs mutation.
Asunto(s)
Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Proteína P0 de la Mielina/genética , Proteína P0 de la Mielina/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Vías Aferentes/patología , Vías Aferentes/fisiopatología , Sustitución de Aminoácidos/genética , Animales , Adhesión Celular/genética , Adhesión Celular/fisiología , Línea Celular , Preescolar , Citoplasma/química , Proteínas Fluorescentes Verdes , Neuropatía Hereditaria Motora y Sensorial/genética , Neuropatía Hereditaria Motora y Sensorial/patología , Neuropatía Hereditaria Motora y Sensorial/fisiopatología , Humanos , Indicadores y Reactivos , Insectos , Masculino , Microscopía Fluorescente , Mutagénesis Insercional/genética , Proteína P0 de la Mielina/fisiología , Conducción Nerviosa/genética , Conducción Nerviosa/fisiología , Proteínas Recombinantes de Fusión/síntesis química , Nervio Sural/química , Nervio Sural/metabolismo , Nervio Sural/patología , Nervio Sural/fisiopatología , TransfecciónRESUMEN
Peripheral nervous system (PNS) possess both classical (e.g. progesterone receptor, PR, androgen receptor, AR) and non-classical (e.g. GABA(A) receptor) steroid receptors and consequently may represent a target for the action of neuroactive steroids. Our data have indicated that neuroactive steroids, like for instance, progesterone, dihydroprogesterone, tetrahydroprogesterone, dihydrotestosterone and 3alpha-diol, stimulate both in vivo and in vitro (Schwann cell cultures), the expression of two important proteins of the myelin of peripheral nerves, the glycoprotein Po (Po) and the peripheral myelin protein 22 (PMP22). It is important to highlight that the mechanisms by which neuroactive steroids exert their effects on the expression of Po and PMP22 involve different kind of receptors depending on the steroid and on the myelin protein considered. In particular, at least in culture of Schwann cells, the expression of Po seems to be under the control of PR, while that of PMP22 needs the GABA(A) receptor. Because Po and PMP22 play an important physiological role for the maintenance of the multilamellar structure of the myelin of the PNS, the present observations might suggest the utilization of neuroactive steroids as new therapeutically approaches for the rebuilding of the peripheral myelin.
Asunto(s)
Vaina de Mielina/fisiología , Sistema Nervioso Periférico/fisiología , Esteroides/fisiología , Animales , Humanos , Proteína P0 de la Mielina/fisiología , Proteínas de la Mielina/genética , Proteínas de la Mielina/fisiologíaRESUMEN
Table 1 summarizes the results obtained from expressing in CHO cells C21A P0 and N93A P0 alone, and each with wild-type P0. As can be seen, each of these mutated proteins reach the cell surface when expressed alone, but neither is adhesive. Finally, when each of these mutated P0 molecules is expressed with the wild-type P0, wild-type P0 is no longer adhesive. Therefore, both C21A Po and N93A P0 each have a dominant negative effect on adhesion of wild-type P0. This approach to address the functional consequences of mutations in P0 can now be used to assess the effects of different mutations associated with CMT1B.
Asunto(s)
Adhesión Celular/fisiología , Proteína P0 de la Mielina/fisiología , Mutación Puntual , Sustitución de Aminoácidos , Animales , Células CHO , Cricetinae , Humanos , Modelos Moleculares , Mutagénesis Sitio-Dirigida , Proteína P0 de la Mielina/química , Proteína P0 de la Mielina/genética , Conformación Proteica , TransfecciónRESUMEN
In order to better understand the pathogenesis of demyelination in P0 knockout (P0-/-) mice, we analyzed the myelin gene expression and the localization of myelin proteins in P0 null mouse sciatic nerve. We have demonstrated that the severe demyelinating neuropathy of P0-knockout mouse is associated with changes in the program of myelin gene expression. Some changes in myelin gene expression occur early, others occur during adulthood. We also provide evidence that the absence of P0 is associated with changes in the localization of specific paranodal proteins in the peripheral nerve. These data suggest that P0 plays an important role, either directly or indirectly, in the program of Schwann cell gene expression and in the specific distribution of peripheral myelin proteins. Furthermore, myelin gene dysregulation and improper localization of paranodal proteins may account, in part, for the pathogenesis of demyelination in P0-knockout mice, as well as in human demyelinating peripheral neuropathy associated with mutations in the P0 gene.